About
EyeYon Medical is a start-up company specializing in developing medical ophthalmic devices for complications resulting from various corneal diseases, including corneal edema. EyeYon Medical has developed exclusive technologies that have proven to have a solution to acute problems in the ophthalmic world.
EyeYon Medical's flagship product is an artificial endothelial layer called EndoArt. EndoArt is a synthetic implant attached to the posterior corneal surface to treat chronic corneal edema secondary to endothelial dysfunction. The minimally invasive EndoArt is designed to replace dysfunctional endothelium to cure corneal edema, offering a safe and simple solution that will be available to anyone, anywhere.
EyeYon Medical also developed the Hyper CL, an FDA-approved therapeutic contact lens for a variety of corneal conditions that require eye drop treatment.
Funding history · 4 rounds · $36.1M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is EyeYon Medical's primary focus?
- EyeYon Medical specializes in developing medical ophthalmic devices for complications arising from various corneal diseases, including corneal edema.
- What is EyeYon Medical's flagship product?
- EyeYon Medical's flagship product is EndoArt, an artificial endothelial layer designed as a synthetic implant to treat chronic corneal edema secondary to endothelial dysfunction.
- What is the status of EyeYon Medical's Hyper CL product?
- EyeYon Medical's Hyper CL is an FDA-approved therapeutic contact lens used for various corneal conditions requiring eye drop treatment.
- When did EyeYon Medical receive FDA IDE approval for its EndoArt clinical study in the US?
- In December 2025, EyeYon Medical received FDA IDE approval to initiate a US clinical study for EndoArt, its artificial endothelial layer for corneal edema.
- When did EyeYon Medical expand its operations into China?
- In February 2025, EyeYon Medical expanded into China by establishing a new subsidiary, Zhuhai EyeYon Medical Technology Co.
- When did EyeYon Medical receive the CE Mark for its synthetic implant?
- In June 2021, EyeYon Medical received the CE Mark for its synthetic implant.
- When did EyeYon Medical receive Innovative Medical Device Designation for EndoArt in China?
- In April 2021, EyeYon Medical was granted Innovative Medical Device Designation for its EndoArt® product in China.
- When did EyeYon Medical complete its Series C funding round and who was the lead investor?
- In March 2021, EyeYon Medical completed a Series C funding round, with CR-CP Life Science Fund as the lead investor. For full financing history, refer to startupim.
- When did EyeYon Medical receive Breakthrough Device Designation from the FDA for EndoArt?
- In February 2020, EyeYon Medical received Breakthrough Device Designation from the FDA for its EndoArt® product.